EMB-01 in Combination With Chemotherapy for Unresectable or Metastatic Colorectal Cancer

NCT07649655 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Unresectable/Metastatic Colorectal Cancer

Interventions

DRUG: EMB-01
DRUG: Irinotecan
DRUG: TAS-102
DRUG: mFOLFOX6
DRUG: FOLFIRI

Sponsor

Shanghai EpimAb Biotherapeutics Co., Ltd.